Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,066,000
-22,000 (-2.02%)
At close: Jul 25, 2025, 3:30 PM KST

Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 75.87 trillion as of July 25, 2025. Its market cap has increased by 45.63% in one year.

Market Cap
75.87T
Enterprise Value
76.01T
Revenue
4.90T
Ranking
n/a
PE Ratio
59.30
Stock Price
1,066,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 75.87T, an increase of 696.32%. That is a compound annual growth rate of 26.90%.

History

DateMarket Cap% Change
Jul 25, 202575.87T12.33%
Dec 30, 202467.54T24.87%
Dec 28, 202354.09T-7.43%
Dec 29, 202258.43T-2.20%
Dec 30, 202159.75T9.32%
Dec 30, 202054.65T90.76%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Nov 10, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Celltrion39.24T
ALTEOGEN24.69T
Yuhan9,152.41B
SK Biopharmaceuticals8,034.94B
Peptron6,663.04B
HLB Co., Ltd.6,558.63B
PharmaResearch5,797.42B
Sam Chun Dang Pharm.5,349.22B
Market Cap Rankings